APEX BIOTECHNOLOGY CORP revenue for the last year amounted to 2.29 B TWD, the most of which — 1.11 B TWD — came from its highest performing source at the moment, Test Piece, the year earlier bringing 1.38 B TWD. The greatest contribution to the revenue figure was made by United States — last year it brought APEX BIOTECHNOLOGY CORP 683.99 M TWD, and the year before that — 898.35 M TWD.